Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients

Symptoms of bronchial asthma are a manifestation of airway inflammation. Circulatory leucocytes (predominantly eosinophils, mast cells and neutrophils), release inflammatory mediators, including reactive oxygen species, i.e. superoxide anion which is dismutated to hydrogen peroxide (H2O2). Neutrophils from asthmatics generate greater amounts of these species than those of healthy subjects. Some of the H2O2 and thiobarbituric acid-reactive products (TBARs) can evaporate from alveolar lining fluid, and could be expired from the airways of asthmatics. In this study, therefore, we determined whether asthmatic patients exhale more H2O2 and TBARs than healthy subjects. We examined 10 healthy subjects as a control group and 21 asthmatic subjects. In asthmatic subjects, forced expiratory volume in one second (FEV1), was 68+/-9% of predicted value, peak expiratory flow rate (PEFR) was 65+/-8% pred, and bronchial reversibility was 34+/-5% of prebronchodilated FEV1. The mean H2O2 level measured spectrofluorimetrically in the expired breath condensate of asthmatic subjects was 26 fold higher than that in healthy controls (0.26+/-0.29 vs 0.01+/-0.03 nM; p<0.05). The concentration of TBARs in breath condensate was also higher in asthmatic patients compared with nonasthmatics (0.073+/-0.071 vs 0.004+/-0.009 nM; p<0.05). There was a significant correlation between H2O2 level and concentration of TBARs in asthmatic patients (r=0.74; p<0.01). There was also a strong inverse correlation between H2O2 content of all asthmatics and FEV1% pred (r=-0.63; p<0.005) and PEFR% pred (r=-0.52; p<0.05). We conclude that there are elevated levels of hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients, and that measurement of these substances in the expired breath condensate could be a simple, noninvasive method that could be used as a biochemical marker of airway inflammation.

This article has been cited by other articles:

				P. Chitano, L. Wang, S. N. Mason, R. L. Auten, E. N. Potts, W. M. Foster, A. Sturrock, T. P. Kennedy, J. R. Hoidal, and T. M. Murphy Airway smooth muscle relaxation is impaired in mice lacking the p47phox subunit of NAD(P)H oxidase Am J Physiol Lung Cell Mol Physiol, January 1, 2008; 294(1): L139 - L148. [Abstract] [Full Text] [PDF]

				P. Montuschi Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 5 - 23. [Abstract] [PDF]

				A. R. Wewel, J. A. M. Crusius, U. Gatzemeier, M. Heckmayr, G. Becher, H. Magnussen, R. A. Jorres, and O. Holz Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy. Eur. Respir. J., May 1, 2006; 27(5): 1033 - 1039. [Abstract] [Full Text] [PDF]

				W. Cao and Y. Duan Breath Analysis: Potential for Clinical Diagnosis and Exposure Assessment Clin. Chem., May 1, 2006; 52(5): 800 - 811. [Abstract] [Full Text] [PDF]

				H. M. Ochs-Balcom, B. J. B. Grant, P. Muti, C. T. Sempos, J. L. Freudenheim, R. W. Browne, M. Trevisan, L. Iacoviello, P. A. Cassano, and H. J. Schunemann Oxidative Stress and Pulmonary Function in the General Population Am. J. Epidemiol., December 15, 2005; 162(12): 1137 - 1145. [Abstract] [Full Text] [PDF]

				X. Luo, R. Belcastro, J. Cabacungan, V. Hannam, A. Negus, Y. Wen, J. Plumb, J. Hu, B. Steer, D. R. Koehler, et al. Transfection of lung cells in vitro and in vivo: effect of antioxidants and intraliposomal bFGF Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L817 - L825. [Abstract] [Full Text] [PDF]

				L.G. Wood, P.G. Gibson, and M.L. Garg Biomarkers of lipid peroxidation, airway inflammation and asthma Eur. Respir. J., January 1, 2003; 21(1): 177 - 186. [Abstract] [Full Text] [PDF]

				P. Paredi, S. A. Kharitonov, and P. J. Barnes Analysis of Expired Air for Oxidation Products Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): S31 - 37. [Abstract] [Full Text] [PDF]

				K. Kostikas, G. Papatheodorou, K. Ganas, K. Psathakis, P. Panagou, and S. Loukides pH in Expired Breath Condensate of Patients with Inflammatory Airway Diseases Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1364 - 1370. [Abstract] [Full Text] [PDF]

				G. M. MUTLU, K. W. GAREY, R. A. ROBBINS, L. H. DANZIGER, and I. RUBINSTEIN Collection and Analysis of Exhaled Breath Condensate in Humans Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 731 - 737. [Full Text] [PDF]

				I. Horvath, W. MacNee, F.J. Kelly, P.N.R. Dekhuijzen, M. Phillips, G. Doring, A.M.K. Choi, M. Yamaya, F.H. Bach, D. Willis, et al. "Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases", summary of the ERS Research Seminar in Budapest, Hungary, September, 1999 Eur. Respir. J., August 1, 2001; 18(2): 420 - 430. [Abstract] [Full Text] [PDF]

				S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF]

				S. LIM, D. GRONEBERG, A. FISCHER, T. OATES, G. CARAMORI, W. MATTOS, I. ADCOCK, P. J. BARNES, and K. F. CHUNG Expression of Heme Oxygenase Isoenzymes 1 and 2 in Normal and Asthmatic Airways . Effect of Inhaled Corticosteroids Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1912 - 1918. [Abstract] [Full Text]

				P. PAREDI, S. A. KHARITONOV, and P. J. BARNES Elevation of Exhaled Ethane Concentration in Asthma Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1450 - 1454. [Abstract] [Full Text] [PDF]

				R. Dworski Oxidant stress in asthma Thorax, October 1, 2000; 55(90002): 51S - 53. [Full Text]

				J. C. de JONGSTE and K. ALVING Gas Analysis Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): S23 - 27. [Full Text] [PDF]

				J. F. HUNT, K. FANG, R. MALIK, A. SNYDER, N. MALHOTRA, T. A. E. PLATTS-MILLS, and B. GASTON Endogenous Airway Acidification . Implications for Asthma Pathophysiology Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 694 - 699. [Abstract] [Full Text] [PDF]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				R G Stirling, S A Kharitonov, D Campbell, D S Robinson, S R Durham, K F Chung, and P J Barnes Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids Thorax, December 1, 1998; 53(12): 1030 - 1034. [Abstract] [Full Text]